| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,142 |
27,023 |
$1.52M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,867 |
19,142 |
$1.51M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,837 |
6,296 |
$515K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,840 |
1,726 |
$219K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,802 |
8,229 |
$87K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,908 |
2,761 |
$80K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
658 |
649 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,450 |
1,404 |
$65K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,941 |
1,744 |
$59K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
744 |
709 |
$43K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,894 |
1,652 |
$27K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,682 |
1,381 |
$25K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
57 |
57 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
12 |
$126.90 |
| 81025 |
|
32 |
13 |
$72.48 |
| 99000 |
|
758 |
693 |
$7.25 |
| 81002 |
|
317 |
249 |
$4.88 |
| 81003 |
|
29 |
28 |
$0.00 |